Discover the biggest takeaways from Preseason Week 1! RJ Harvey shines for the Broncos, Breece Hall's workload raises eyebrows, and Travis Hunter plays dual roles for the Jaguars. Get ready for the fantasy football season with these critical insights!
A groundbreaking Harvard study suggests lithium may reverse Alzheimer's-like changes in mice, igniting hope among advocates for earlier detection and new treatments. Experts urge caution and further research.
Tom Lehrer, the beloved humorist and pianist known for his satirical songs, has died at the age of 97. His unique blend of humor and music captivated audiences for decades. Lehrer’s legacy will live on through his witty compositions and impactful activism.
Hershey announces a price increase for its chocolate products due to soaring cocoa prices, driven by poor harvests in West Africa. Learn how climate change is affecting your favorite candies!
In a high-stakes court battle, Harvard and the Trump administration clash over the potential loss of $2.6 billion in federal funding. With accusations of antisemitism and control over the Ivy League's operations, the legal drama unfolds.
Researchers at Fudan and Peking Universities have achieved a groundbreaking observation of the nonlinear Nernst effect in non-magnetic ABA trilayer graphene, paving the way for efficient thermoelectric energy harvesting without magnetic fields.
A groundbreaking study suggests that the sex of a baby may not be random but influenced by family-specific factors like maternal age and genetics, challenging long-held beliefs.
As Trump navigates his first 100 days, he faces declining approval ratings, a tariff agreement with China, and a contentious battle with Harvard over funding. Discover the key highlights and challenges of his presidency so far.
The Trump administration resumes student visa appointments but enforces strict social media vetting to screen for potential hostility towards the U.S. This move raises concerns about free speech and its implications for foreign students.
In a bold move, a Turkish private equity firm has injected $39 million into a Harvard lab, aiming to pioneer new therapies for metabolic conditions. This unique financing approach could reshape academic funding in the future.
